← All providers

HealthRX vs Midi Health

Compare pricing, features, and medications to find the best GLP-1 provider for your weight loss journey

HealthRX vs Midi Health: Overview

Choosing between HealthRX and Midi Health for GLP-1 weight loss medication? Both are highly-rated providers, but they differ in pricing, medication options, and service features.

HealthRX offers both semaglutide and tirzepatide at $133/month with a rating of 8.5/10. Midi Health also provides both semaglutide and tirzepatide at $164/month with a 8.6/10 rating.

With only a $31/month price difference, your choice will likely come down to features, support quality, and medication options.

Our recommended brand

After reviewing all 148 providers on this platform, we've identified CoreAge Rx as offering the most transparent pricing model. At just $99/month — the same price every month, every dose — there are no surprise charges or hidden fees. Combined with exceptional service quality, personalized support, and access to both semaglutide and tirzepatide, it represents the best value without compromising on care.

Visit CoreAge Rx →Read full review

At a glance

Price Difference

$31/mo

Rating Difference

0.1

Winner

Midi Health

Best For

Quality

HealthRX

View full HealthRX review →

Rating

8.5/10

Monthly Price

$133Cheaper

Medications

semaglutidetirzepatide

Pros

✓Efficacy claims are cited to the actual trials with duration and source: 'Average 15% body-weight loss at 68 weeks in STEP-1' for semaglutide and 'Average 21% body-weight loss at 72 weeks in pivotal phase-3 trial' for tirzepatide, referencing NEJM 2021, each followed immediately by 'Not FDA-approved'
✓The competitor price comparison is dated and sourced - 'published monthly prices at comparable telehealth clinics, July 2026' and 'Prices as displayed on each clinic's public site' - rather than an unattributed claim of being cheapest
✓LegitScript certification is given with its certificate number (50087439), so it can be independently verified
✓Pricing is low and clearly tiered: compounded semaglutide from $133/mo on a 3-month plan or $99/mo on 12 months, and tirzepatide from $209/mo or $179/mo on 12 months (checked July 27, 2026)
✓Same price at every dose, so titration does not raise the bill
✓Full refund if a licensed provider does not approve you, and the site states outright that paying does not guarantee a prescription
✓Cancel anytime 'in one click', with free overnight cold-chain shipping and availability in all 50 states
✓The 503A regulatory category is named specifically rather than the vaguer 'FDA-registered facility' language competitors prefer

Cons

✗The '4.8 · 12,000+ members' rating shown in the header has no traceable source - we found no Trustpilot profile for the domain and no other public review platform carrying it
✗The advertised prices are plan prices, not month-to-month rates. '$133/mo' is the 3-month plan and '$99/mo' requires committing to a full year; no single-month price is displayed
✗Committing 12 months upfront to a compounded medication means paying for a year before you know how you tolerate it
✗No BBB profile or independent complaint record exists to check the service against
✗No published customer phone number or support hours
✗The competitor comparison, while dated and sourced, is still marketing produced by the company that benefits from it
✗As with every compounded GLP-1, the trial figures quoted come from the branded medicines rather than the compounded product actually dispensed - HealthRX says so, but the numbers still headline the page

Choose HealthRX

Midi Health

View full Midi Health review →

Rating

8.6/10Better

Monthly Price

$164

Medications

compounded GLP-1compounded GLP-1/GIPbrand-name GLP-1s

Pros

✓The GLP-1 pricing page is the most transparent we have seen anywhere in this category: a dose-by-dose table for four different products, with shipping and supplies included in every figure (checked July 28, 2026)
✓Compounded GLP-1 injectable runs $165.90 for the lowest doses, $270.90 in the mid range and $355.00 at the top; the dual-action GLP-1/GIP injectable runs $210.00 to $434.00, all for a 4-week supply
✓Sublingual options are offered as well, from $164.00 for GLP-1 and $209.00 for dual-action GLP-1/GIP, for people who will not inject
✓Its partner compounding pharmacies are 503B-accredited. 503B outsourcing facilities register with the FDA, are subject to current good manufacturing practice requirements and are FDA-inspected - a materially higher standard than the 503A pharmacies most competitors use
✓There is no membership fee. You pay for care and medication only
✓Visits are insurance-covered for qualifying patients, and HSA/FSA funds can be used for copays and services
✓Midi will also prescribe brand-name GLP-1s sent to a pharmacy of your choice, so you are not locked into compounded product if you would rather have the approved drug
✓The efficacy claim is the best-sourced in this category. Midi reports patients lost an average of 16 lbs after six or more months, and footnotes it to a retrospective analysis of 6,958 patients who completed two or more weight management visits between 1 May 2025 and 30 April 2026, while stating plainly that weight data were self-reported and results are not guaranteed
✓Care is genuinely whole-person for midlife women - perimenopause, menopause, weight, mood and memory, sexual wellness, hair and skin, sleep, and cancer survivorship - with lab orders and lifestyle support included where appropriate
✓Available in all 50 states

Cons

✗The compounded products are still not FDA-approved. 503B accreditation raises the manufacturing standard considerably but does not mean the FDA has reviewed these preparations for safety or efficacy
✗Midi never names the active drug anywhere in its pricing. Everything is labelled 'GLP-1' or 'GLP-1/GIP'. The dose ladders shown - 0.25 through 2.5 mg, and 2.5 through 15 mg - match the standard semaglutide and tirzepatide titrations exactly, but you should confirm with the clinician what you are actually being prescribed
✗Microdosing is offered from $34 a week for eligible patients. Microdosing is not an evidence-based protocol - the trials behind these drugs used full therapeutic doses, and the 16 lb outcome figure covers patients on 'a range of treatments', not microdosing specifically
✗Medicaid and Medi-Cal patients cannot be treated at all, even if they offer to pay cash
✗Medicare does not cover Midi, and beneficiaries cannot submit claims for visits, medications or associated services
✗Prices rise steeply as you titrate up. Injectable GLP-1 more than doubles from $165.90 to $355.00, and the dual-action sublingual runs from $209.00 to $460.00, so the entry price is not what you will pay long term
✗The 16 lb average comes from self-reported weights in a retrospective chart review with no control group - well documented, but not a controlled trial
✗GLP-1 medications are not suitable for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, or during pregnancy. Pancreatitis and gallbladder disease are recognised risks

Choose Midi Health

Feature-by-feature comparison

Feature	HealthRX	Midi Health
Monthly Price	$133	$164
Rating	8.5/10	8.6/10
Medications	semaglutide, tirzepatide	compounded GLP-1, compounded GLP-1/GIP, brand-name GLP-1s
Insurance Accepted	No	Yes
Support Hours	Not published	Not published
Live Chat	No	No
Free Shipping	Yes	Yes
Shipping Speed	Free overnight shipping, ships cold in 24-48 hours	Discreet shipping included in every quoted medication price
Mobile App	No	No
Dedicated Coach	Not included	Not included
Follow-up Frequency	Provider review and ongoing support included	Continued care visits with the same clinician, covered by insurance for qualifying patients
Money-back Guarantee	Full refund if a licensed provider does not approve you for treatment	None published
Cancellation Policy	Cancel anytime in one click; plan prices are paid upfront for the term selected	No membership fee and no subscription lock-in; you pay for care and medication only

Which should you choose?

Choose HealthRX if you:

→Want to save $31/month with a more affordable option
→Value: efficacy claims are cited to the actual trials with duration and source: 'average 15% body-weight loss at 68 weeks in step-1' for semaglutide and 'average 21% body-weight loss at 72 weeks in pivotal phase-3 trial' for tirzepatide, referencing nejm 2021, each followed immediately by 'not fda-approved'

Get started with HealthRX

Choose Midi Health if you:

→Prefer a higher-rated service (8.6/10 vs 8.5/10)
→Want more medication options to choose from
→Need insurance coverage for your treatment
→Value: the glp-1 pricing page is the most transparent we have seen anywhere in this category: a dose-by-dose table for four different products, with shipping and supplies included in every figure (checked july 28, 2026)

Get started with Midi Health

Website previews

HealthRX

HealthRX website

Midi Health

Midi Health website

Our recommendation

Midi Health comes out ahead with a higher rating of 8.6/10. It also provides multiple medication options including both semaglutide and tirzepatide.

Get started with Midi Health

Related comparisons

HealthRX vs CoreAge Rx

HealthRX vs Zepbound

HealthRX vs Mounjaro

HealthRX vs Wegovy Pill

HealthRX vs Foundayo

HealthRX vs Wegovy

HealthRX vs NovoCare Pharmacy

HealthRX vs Ozempic

HealthRX vs Form Health

HealthRX vs Henry Meds

HealthRX vs Sesame Care

HealthRX vs FuturHealth

HealthRX vs Circle Medical

HealthRX vs Ro

HealthRX vs Noom Med

HealthRX vs Precision Telemed

HealthRX vs Hims

HealthRX vs Calibrate

HealthRX vs PlushCare

HealthRX vs LifeMD

Compare other providers

Compare GLP-1 Brands

First Brand

vs

Second Brand